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After the reduction of poliomyelitis, Guillain–Barre syndrome (GBS) has become the most common cause of acute flaccid paralysis in the developed and developing countries. Its 
incidence is 0.6–4 individuals per lakh population per year [1]. It is a 
post-infectious polyneuropathy involving mainly motor nerves, but 
sensory and autonomic nerves might also be involved. Most patients 
have demyelinating neuropathy, but few patients might have primary 
axonal degeneration [2]. Although it is considered a monophasic 
illness, GBS can recur in 1–6% of patients. It has been reported to 
occur in 1–10% of patients after an asymptomatic period of several 
months to years [3-5]. Risk factors for recurrent GBS (RGBS) 
include age less than 30, milder symptoms, and history of Miller-
Fisher syndrome (MFS) variant in the first episode [6].
A recurrence was defined as two or more episodes that fulfilled 
the National Institute of Neurological and Communicative 
Disorders and Stroke criteria for GBS, with a minimum time 
period of 2 months between episodes (when fully recovered 
in between) or 4 months (when only partially recovered) [7]. 
There appears to be no significant difference between GBS and 
RGBS episodes with respect to clinical symptoms and triggering 
events. It is important to know that there is always a possibility of 
recurrence in GBS and parents should be counseled accordingly.
CASE REPORT
A 12-year-old girl presented with a second attack of GBS after 
an asymptomatic period of 6 years. During the first attack, 
she was admitted to our hospital with the chief complaint of 
weakness and difficulty in walking since morning. She had 
a history of upper respiratory tract infection (URTI) 15 days 
back which was cured. Examination revealed acute-onset 
quadriparesis with areflexia with a power of 2/5 in upper and 1/5 
in both lower limbs. The rest of the systemic examination along 
with bowel and bladder movements was normal. Hemogram, 
liver function tests, renal function tests, and electrolytes were 
within normal limits. She was diagnosed as a case of GBS 
and treated with intravenous immunoglobulin (IVIg) (2 gm/
kg) over 5 days. Nerve conduction study was suggestive of 
acute motor axonal neuropathy (AMAN). Cerebrospinal fluid 
(CSF) study showed albuminocytological dissociation (2 cells, 
all lymphocytes, sugar 75 mg/dl, and protein 80 mg/dl). She 
was discharged after 14 days of hospitalization with a power 
of 3/5 in all limbs. She was able to walk without support after 
3 months. Since then, she has been normal without any residual 
disability.
After 6 years during the second episode, she presented with 
similar complaint of difficulty in walking and swallowing. She 
had a history of URTI 15 days back. Examination revealed 
quadriparesis (power 0/5 in all limbs). Her single breath count was 
8 and there was pooling of secretions in the mouth. Subsequently, 
she was intubated and ventilated. She was diagnosed as a case of 
RGBS and was treated with IVIg (2 gm/kg) over 5 days, along 
with supportive therapy. Nerve conduction velocity study showed 
severe AMAN. Her CSF study showed an albuminocytological 
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dissociation (1 cell, all lymphocytes, sugar – 77 mg/dl, and 
protein – 126 mg/dl).
In view of slow improvement and anticipated prolonged 
ventilation, tracheostomy was done after 10 days. She remained 
on the ventilator for 75 days and tracheostomy was closed after 
90 days. At the time of discharge, power in both upper limbs was 
4/5 and lower limbs was 3/5. Compared to the previous episode, 
this episode was more severe with respiratory involvement 
requiring mechanical ventilation, tracheostomy and prolonged 
intensive care unit stay, and slow response to IVIg.
DISCUSSION
GBS is an acute, immune-mediated inflammatory 
polyradiculoneuropathy involving the peripheral nervous system. 
Onset is preceded by an antecedent event in two-thirds of the 
patients, usually a URTI or a diarrheal illness [1,2], where the 
causative agent is assumed to trigger an immune response against 
the gangliosides and glycolipids distributed along the myelin 
sheaths and peripheral nervous system. This results in marked 
inflammation of the peripheral nerves, resulting in demyelination 
and defective impulse propagation. It is a heterogeneous group of 
disorders which involves motor, sensory, and autonomic nervous 
systems to varying degrees depending on the subtype; (1) acute 
inflammatory demyelinating polyneuropathy, (2) AMAN, 
(3) acute motor-sensory axonal neuropathy, (4) MFS, (5) acute 
pan-autonomic neuropathy, and (6) pure sensory GBS.
RGBS is a rare entity that has been reported in about 1–6% 
of GBS patients [3]. This is the first case of RGBS from our 
unit in 20 GBS patients in the past 5 years. There are only a few 
published case studies that include children with RGBS [1,3-5]. 
The most comprehensive study reported by Dr. R. H. Kennedy 
and colleagues  at Mayo Clinic in 1978, retrospectively followed 
40 GBS patients for up to 42 years after the first attack, and only 
one individual had the second episode of GBS, which occurred 
4 years after the initial one [6].
The time lag between two episodes of GBS was 
4 months–10 years in a study done by Das et al. [3] and a mean 
of 7 years with a range from 2 months to 37 years as described 
by Kuitwaard et al. [2]. A case report by Md Mohabub from 
Bangladesh had a lag period of 17 years, whereas in our case, 
it was 6 years. In a study of 49 RGBS patients by Kuitward et 
al., one-third of the patients presented with same, one-third with 
more, and one-third with less huges disability score [2]. Our 
patients presented with similar signs and symptoms, but with an 
increase in the severity and respiratory involvement requiring 
ventilation. Recovery from the second episode was very slow as 
compared to the first episode.
In the same study by Kuitward et al., 65% of patients had 
similar and 35% had different antecedent infections in recurrent 
episodes, which indicated that there is some genetic basis 
for the disease [2]. Studies by Taly et al. and Hayashi et al. 
have reported different antecedent events in individual RGBS 
patients [7,8]. In contrast, Wijdicks and Ropper described 
similar antecedent illnesses in individual RGBS patients [9]. 
In our patients, URTI was the preceding infection in both 
the episodes. Most of the patients had either pure motor or 
sensory-motor symptoms in subsequent episodes. None of the 
patients initially had GBS in one episode followed by MFS in 
a subsequent episode. In contrast to the case report by M. Dy 
et al., where the patient developed different variant, our patients 
had similar motor axonal neuropathy with more severity [10]. 
RGBS is more common in patients with demyelinating variety, 
but rarely with axonal alone. In our case, it is axonal variant. 
Nerve conduction study are similar in demylinating variety of 
RGBS but one case report of Japanese patient showed sensory 
variation.[11]
There is no specific predictor of RGBS but age less than 30, 
milder symptoms, and history of MFS variant in the first episode 
are the few risk factors [12]. Most patients with RGBS develop one 
episode, but patients with two or more episodes are described with 
recurrence occurring months to years after the first episode [2]. 
Pathogenesis of RGBS is not clear, but an immunological and 
genetic basis is suspected because different types of the trigger 
result in similar presentation, recurrence is more common with 
MFS variant (have anti-GQ 1 antibody). In the study by Kuitward 
et al., three patients of RGBS had different autoimmune diseases, 
which suggest a genetic basis for the disease.
CONCLUSION
To the best of our knowledge, this is the first case report of 
axonal phenotype RGBS in a child from eastern India. This case 
highlights that GBS is not a monophasic illness and recurrence 
of GBS, though rare, might be seen in children. RGBS is an 
underrecognized and underdiagnosed entity in pediatric patients. 
Future researches are needed to further study the epidemiology 
and pathophysiology of the disease.
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